BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1703108)

  • 1. Prognostic significance of neoplastic cell proliferation parameters in human haematological malignancies.
    Kotelnikov VM
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):391-7. PubMed ID: 1703108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of minimal malignant cell infiltration in the bone marrow of patients with solid tumours, non-Hodgkin lymphomas and leukaemias.
    Favrot MC; Hervé P
    Bone Marrow Transplant; 1987 Aug; 2(2):117-22. PubMed ID: 3502784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary result of dynamic contrast-enhanced MR imaging in assessment of cellularity characteristics of bone marrow in patients with haematological malignancies].
    Zhang L; Mandel C; Yang ZY; Wang PJ; Pitman AG
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):202-5. PubMed ID: 17649637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
    Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
    Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The mechanism of cell proliferation in acute (immature-cell) leukemia].
    Urasiński I; Kordecki H
    Acta Haematol Pol; 1977; 8(3):205-212. PubMed ID: 270271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
    Glasová M; Koníková E; Stasáková J; Babusíková O
    Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive significance of parameters of tumor cell proliferation].
    Kotel'nikov VM
    Eksp Onkol; 1989; 11(5):3-9. PubMed ID: 2676470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frequency distribution of DNA in blood and bone marrow cells of children with acute non-lymphatic leukemia using impulse cytophotometry].
    Exadaktylos P; Schlette O; Rumler W; Weidhase R; Haerting J; Reiss T; Heinrichs I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):610-6. PubMed ID: 2448199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical study of micro-metastatic cancer by bone biopsy.
    Burkhardt R; Frisch B; Kettner G
    Bull Cancer; 1980; 67(3):291-305. PubMed ID: 7407427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histopathology of leukaemic non-Hodgkin's lymphoma in bone marrow].
    Buhr T; Länger F; Schlué J; V Wasielewski R; Kreipe H
    Pathologe; 2002 Nov; 23(6):438-47. PubMed ID: 12436297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
    Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
    Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on cell kinetics in leukemia using flow cytometry].
    Yoshida K
    Hokkaido Igaku Zasshi; 1982 Sep; 57(5):557-71. PubMed ID: 7152463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM
    Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma].
    Pasqualetti P; Colantonio D; Casale R
    Minerva Med; 1990 Mar; 81(3):129-33. PubMed ID: 2320280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth kinetics and blast-colony forming cell binding capacity of stromal cells in various haematological malignancies.
    el-Khatib Y; Gidáli J; Fehér I; Mód A; Poros A; Hollán S
    Haematologia (Budap); 1991; 24(2):77-82. PubMed ID: 1816058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and pattern of liver involvement in haematological malignancies.
    Walz-Mattmüller R; Horny HP; Ruck P; Kaiserling E
    Pathol Res Pract; 1998; 194(11):781-9. PubMed ID: 9842637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of cytogenetic aberrations in patients with multiple myeloma or monoclonal gammopathy of unknown significance.
    Schilling G; Dierlamm J; Hossfeld DK
    Hematol Oncol; 2005; 23(3-4):102-7. PubMed ID: 16342296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartments.
    Kumar S; Rajkumar SV; Greipp PR; Witzig TE
    Am J Hematol; 2004 Sep; 77(1):7-11. PubMed ID: 15307099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.